Pharmaceutical News

RSS

MU medicinal chemists create more potent, efficient weapon against cancer

Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs. In a new study, MU medicinal chemists have taken an existing drug that is being developed for use in fighting certain types of cancer, added a special structure to it, and created a more potent, efficient weapon against cancer.

30 Aug 2012

UTMB to offer HPV vaccination against cervical cancer

University of Texas Medical Branch at Galveston's Dr. Abbey Berenson has been awarded a $1.2 million grant to start a program that will provide a vaccination against cervical cancer to many hundreds of low-income women who receive health care services at UTMB.

30 Aug 2012

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

RegeneRx Biopharmaceuticals, Inc. reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.

30 Aug 2012

Noven submits LDMP NDA with FDA to treat menopausal vasomotor symptoms

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has submitted to the U.S. Food & Drug Administration a New Drug Application (NDA) seeking approval to market low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms associated with menopause.

30 Aug 2012

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

30 Aug 2012

FDA grants orphan designation to Aerial BioPharma’s ARL-N05 for treatment of narcolepsy

Aerial BioPharma, a biopharmaceutical company focused on developing biologics and small molecules for conditions in the central nervous system, has received orphan drug designation for its narcolepsy drug in development.

30 Aug 2012

Jobless working-age people with diabetes less likely to adhere to their medications

If you're diabetic or prone to diabetes, having a steady job appears to be good for your health, and not just because of the insurance coverage.

30 Aug 2012

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma.

30 Aug 2012

ALK signs agreement to supply PRE-PEN to HealthTrust member facilities

ALK is pleased to announce that it has signed an agreement with HealthTrust Purchasing Group, LP to supply PRE-PEN (benzylpenicilloyl polylysine injection USP) the only FDA approved skin test for the diagnosis of penicillin allergy, to HealthTrust member facilities, including 1,400 acute care facilities, 10,600 ambulatory surgery centers, physician practices and alternate care sites.

30 Aug 2012

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines on the Management of Acute Myocardial Infarction in Patients Presenting with Persistent ST-Segment Elevation (STEMI)" guidelines.

29 Aug 2012

New method simplifies pharmaceutical production of proteins

Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular degeneration.

29 Aug 2012

Voters need more information on free trade agreement that could impact drug prices

In an opinion piece in the Guardian's "Comment is Free" blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the "Trans-Pacific Partnership Agreement (TPP), a pact that the United States is negotiating with Australia, Canada, Japan and eight other countries in the Pacific region."

29 Aug 2012

Top 10 reasons to avoid flu shots this year

It's the gift that keeps on giving, from early fall, through the holiday season and into late spring. It's seasonal flu, caused by a virus that can fly through the air, hitch a ride on a handshake, hug or kiss, and is extremely good at infecting people and making them sick.

29 Aug 2012

TaiMed, WuXi enter ibalizumab manufacturing agreement

WuXi PharmaTech today announced that it has a contract manufacturing agreement with TaiMed Biologics Inc. for the manufacture of ibalizumab (TMB-355) in support of Phase 2 and Phase 3 clinical trials globally.

29 Aug 2012

Acorda’s GGF2 can improve erectile function after cavernous nerve damage

Acorda Therapeutics, Inc. announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN) injury, a common complication of prostate surgery.

29 Aug 2012

MMV390048 shows potent activity against multiple points in malaria parasite's lifecycle

A recently discovered compound from the aminopyridine class not only has the potential to become part of a single-dose cure for all strains of malaria, but might also be able to block transmission of the parasite from person to person, according to a research collaboration involving the Medicines for Malaria Venture (MMV), based in Switzerland, and the Drug Discovery and Development Centre (H3-D) at the University of Cape Town, South Africa.

29 Aug 2012

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

29 Aug 2012

GeneTex to introduce new antibody against hypoxia-inducible factor 1alpha

GeneTex, Inc., a leading manufacturer of antibodies, has announced that they will be launching a new antibody against HIF1a (hypoxia-inducible factor 1alpha).

29 Aug 2012

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

In one of the most comprehensive peer-reviewed discussions on cancer vaccines and immunotherapeutics, a Special Focus in the journal Human Vaccines & Immunotherapeutics provides a critical view on cancer vaccines and a discussion on best approaches for the future.

28 Aug 2012

High doses of vitamin B3 stimulate CEBPE gene, enhance WBCs’ ability to combat staph infections

Cedars-Sinai researchers have found that a common vitamin may have the potential to provide a powerful weapon to fight certain "superbugs," antibiotic-resistant staph infections that health experts see as a threat to public health.

28 Aug 2012

Pharmaceutical News

MU medicinal chemists create more potent, efficient weapon against cancer

UTMB to offer HPV vaccination against cervical cancer

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

Noven submits LDMP NDA with FDA to treat menopausal vasomotor symptoms

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

FDA grants orphan designation to Aerial BioPharma’s ARL-N05 for treatment of narcolepsy

Jobless working-age people with diabetes less likely to adhere to their medications

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

ALK signs agreement to supply PRE-PEN to HealthTrust member facilities

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

New method simplifies pharmaceutical production of proteins

Voters need more information on free trade agreement that could impact drug prices

Top 10 reasons to avoid flu shots this year

TaiMed, WuXi enter ibalizumab manufacturing agreement

Acorda’s GGF2 can improve erectile function after cavernous nerve damage

MMV390048 shows potent activity against multiple points in malaria parasite's lifecycle

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

GeneTex to introduce new antibody against hypoxia-inducible factor 1alpha

Human Vaccines & Immunotherapeutics Special Focus provides critical view on cancer vaccines

High doses of vitamin B3 stimulate CEBPE gene, enhance WBCs’ ability to combat staph infections

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News